GLOBEFLEX CAPITAL L P - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 89 filers reported holding RECRO PHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GLOBEFLEX CAPITAL L P ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q1 2020$645,000
-58.2%
78,887
-6.3%
0.20%
-31.5%
Q4 2019$1,544,000
+49.3%
84,219
-9.7%
0.29%
+27.9%
Q3 2019$1,034,000
+103300.0%
93,310
+92286.1%
0.23%
Q4 2016$1,0000.0%1010.0%0.00%
Q3 2016$1,0000.0%1010.0%0.00%
Q2 2016$1,0000.0%1010.0%0.00%
Q1 2016$1,0001010.00%
Other shareholders
RECRO PHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 2,202,420$6,145,0003.11%
Samjo Capital LLC 560,000$1,562,0001.16%
MAK CAPITAL ONE LLC 1,224,264$3,416,0000.81%
Cowen Prime Services LLC 470,500$1,313,0000.50%
Portolan Capital Management 1,957,283$5,461,0000.43%
Parkman Healthcare Partners LLC 601,967$1,679,0000.39%
Rubric Capital Management LP 1,076,587$3,004,0000.18%
Frontier Wealth Management LLC 49,112$2,142,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 466,992$1,303,0000.16%
AWM Investment Company, Inc. 391,304$1,092,0000.12%
View complete list of RECRO PHARMA INC shareholders